Šárka Pospíšilová

26PUBLICATIONS
187CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 21, 2025
Germline Jak2-R1063H mutation interferes with normal hematopoietic development and increases risk of thrombosis and leukemic transformation.

Veronika Zimolova, Monika Burocziova, Linda Berkova

|Jun 30, 2025
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Ferran Nadeu, Shimin Shuai, Guillem Clot

|Apr 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

Birna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton

|Jan 22, 2025
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Sarka Pavlova, Jitka Malcikova, Lenka Radova

|Dec 10, 2024
In vitro culture of leukemic cells in collagen scaffolds and carboxymethyl cellulose-polyethylene glycol gel.

Hana Svozilova, Lucy Vojtova, Jana Matulova

|Sep 11, 2024
The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.

Daniel Hägerstrand, Blaž Oder, Diego Cortese

Pageof 5

Frequent Collaborators

12 joint publications

Michael Doubek

8 joint publications

Karla Plevova

6 joint publications

Richard Rosenquist

6 joint publications

Sarka Pavlova